| Satish Kohli, MD | |
|
3340 W Okmulgee St, Muskogee, OK 74401-5069 | |
| (918) 687-6002 | |
| (918) 687-6216 |
| Full Name | Satish Kohli |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 47 Years |
| Location | 3340 W Okmulgee St, Muskogee, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013091966 | NPI | - | NPPES |
| 100007810A | Medicaid | OK | |
| 110020358 | Other | RAIL ROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 16291 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Francis Hospital Muskogee Inc | 7315216215 | 17 |
| Warren Clinic Inc | 8820900293 | 604 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Laureate Psychiatric Clinic And Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710985064 PECOS PAC ID: 3971599218 Enrollment ID: O20040422000800 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Saint Francis Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144228487 PECOS PAC ID: 9537061171 Enrollment ID: O20070330000494 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Saint Francis Hospital South Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376561944 PECOS PAC ID: 7113829847 Enrollment ID: O20080624000603 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Saint Francis Hospital Vinita, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700334232 PECOS PAC ID: 7911289780 Enrollment ID: O20180308001897 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Entity Name | Saint Francis Hospital Muskogee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386188837 PECOS PAC ID: 7315216215 Enrollment ID: O20180731002274 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Satish Kohli, MD 6600 S Yale Ave, Ste 1400, Tulsa, OK 74136-3331 Ph: (918) 687-6002 | Satish Kohli, MD 3340 W Okmulgee St, Muskogee, OK 74401-5069 Ph: (918) 687-6002 |
News Archive
The cause of the allergic reaction are T lymphocytes (T cells). These cells are part of the body's defences and normally react to viruses or bacteria in the skin.
Researchers of KIT and the Center for Nanotechnology (CeNTech), Münster, have now developed a clinical method to reliably detect and isolate single cancer cells in blood samples in cooperation with the University Hospital of Hamburg-Eppendorf (UKE).
PsiOxus Therapeutics, Ltd. (PsiOxus), a development stage biotechnology company, has completed patient enrollment for its Phase II clinical trial to study MT-102, a small molecule therapeutic for the treatment of cancer cachexia.
Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.
› Verified 3 days ago
Dr. Ken Kuykendall, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 333 S 38th St, Muskogee, OK 74401 Phone: 918-682-8631 Fax: 918-682-2280 | |
Dr. Sang Gang Lee, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 615 S 32nd St, Muskogee, OK 74401 Phone: 918-687-3994 Fax: 918-687-1809 | |
Dr. Ravikumar Vasireddy, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 301 N. 32nd St., Muskogee, OK 74401 Phone: 918-683-2000 Fax: 918-686-0554 | |
Dr. Naga Manohar Javvaji, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 333 S 38th St, Suite A, Muskogee, OK 74401 Phone: 918-682-8631 | |
Dr. Adel George Kyrollos, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: Ccom Medical Group, Inc., 350 S. 40th Street, Muskogee, OK 74401 Phone: 918-683-0753 | |
Mrs. Leslie Ann Eddleman, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1328 S York St, Muskogee, OK 74403 Phone: 918-683-0470 Fax: 918-683-0475 |